<DOC>
	<DOCNO>NCT00574548</DOCNO>
	<brief_summary>The objective study compare safety , tolerability immunologic response dose 23vPS 13vPnC give one year either 13vPnC 23vPS subject never receive previous dose 23vPS .</brief_summary>
	<brief_title>Study Evaluating Safety , Tolerability Immunogenicity 13vPnC 2-Dose Regimen With 23vPS</brief_title>
	<detailed_description />
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>Heptavalent Pneumococcal Conjugate Vaccine</mesh_term>
	<criteria>Male Female , age 60 64 year . Healthy . Previous vaccination license experimental pneumococcal vaccine . History severe adverse reaction associate vaccine . Immunodeficiency .</criteria>
	<gender>All</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>July 2011</verification_date>
	<keyword>Vaccines , Pneumococcal Conjugate Vaccine</keyword>
</DOC>